Simcere Pharmaceutical Group Limited
HKEX:2096.HK
6.22 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2012 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 740.038 | 888.154 | 1,401.797 | 805.088 | 1,081.815 | 929.044 | 497.284 | 56.957 |
| Depreciation & Amortization
| 309.594 | 282.928 | 251.807 | 222.329 | 162.509 | 120.003 | 104.144 | 131.584 |
| Deferred Income Tax
| 0 | -8.275 | -1,118.804 | -574.64 | -265.768 | -231.632 | 47.444 | 0 |
| Stock Based Compensation
| 12.119 | 138.29 | 62.392 | 32.797 | 14.151 | 5.695 | 15.15 | 20.437 |
| Change In Working Capital
| -946.751 | 79.074 | -769.246 | -462.178 | -290.88 | -55.437 | 244.946 | 190.155 |
| Accounts Receivables
| -322.898 | 74.837 | -545.202 | -542.151 | -386.394 | -254.599 | -26.404 | 184.379 |
| Inventory
| -376.639 | -116.794 | -8.33 | -35.461 | -20.05 | -49.195 | 20.219 | 5.776 |
| Accounts Payables
| 0 | -74.837 | 545.202 | 542.151 | 386.394 | 0 | 0 | 0 |
| Other Working Capital
| -247.214 | 195.868 | -760.916 | -426.717 | -270.83 | -6.242 | 224.727 | 0 |
| Other Non Cash Items
| 36.048 | -25.459 | -29.916 | 73.335 | 70.976 | 8.144 | 30.108 | 125.037 |
| Operating Cash Flow
| 151.048 | 1,354.712 | -201.97 | 96.731 | 772.803 | 775.817 | 939.076 | 313.578 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -483.182 | -678.005 | -209.488 | -352.841 | -507.658 | -335.216 | -292.2 | -73.349 |
| Acquisitions Net
| 906.2 | 335.19 | 44.646 | 120.177 | -154.309 | -20 | -10.2 | 0 |
| Purchases Of Investments
| -68.485 | -344.786 | -1,489.402 | -103.772 | -1,670.406 | -896.712 | -1,407.764 | 0 |
| Sales Maturities Of Investments
| 949.097 | 824.287 | 451.124 | 764.567 | 974.753 | 1,154.075 | 804.691 | 0 |
| Other Investing Activites
| -215.823 | -68.38 | 767.617 | 100.952 | 764.692 | -374.548 | 397.083 | 7.72 |
| Investing Cash Flow
| 1,087.807 | 68.306 | -435.503 | 529.083 | -592.928 | -472.401 | -508.39 | -65.629 |
| Financing Activities: | ||||||||
| Debt Repayment
| -151.071 | -316.375 | -1,477.987 | 267.253 | 592.094 | 961.559 | -76.697 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 3,007.932 | 43.91 | 13.849 | 0 | 0 |
| Common Stock Repurchased
| -289.073 | 0 | 0 | 0 | 0 | 0 | 0 | -121.923 |
| Dividends Paid
| -419.218 | -391.296 | -391.296 | 0 | -912.054 | -549.056 | 0 | 0 |
| Other Financing Activities
| -35.472 | -46.01 | 244.752 | -921.563 | -692.99 | -115.067 | -266.23 | -279.583 |
| Financing Cash Flow
| -894.834 | -753.681 | -1,624.531 | 2,353.622 | -1,012.95 | 311.285 | -347.317 | -279.583 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 4.829 | 15.124 | -35.098 | -63.999 | 0.232 | 0.362 | -0.118 | -0.054 |
| Net Change In Cash
| 348.85 | 684.461 | -2,297.102 | 2,915.437 | -832.843 | 615.063 | 83.251 | -31.688 |
| Cash At End Of Period
| 2,007.162 | 1,657.6 | 973.139 | 3,270.241 | 354.804 | 1,187.647 | 572.584 | 178.162 |